Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents

European Journal of Cancer

Volumn 48, Issue 9, 2012, Pages 1407-1413

  Ushio, Soichiro ^a   Egashira, Nobuaki ^a   Sada, Hikaru ^a   Kawashiri, Takehiro ^a   Shirahama, Masafumi ^a   Masuguchi, Ken ^a   Oishi, Ryozo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Allodynia; Anti tumour activity; Goshajinkigan; Hyperalgesia; Neuropathy; Oxaliplatin

Indexed keywords

ELPLAT; GOSHAJINKIGAN; KAMPO; OXALIPLATIN; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; HYPERALGESIA; MALE; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUGS, CHINESE HERBAL; HERB-DRUG INTERACTIONS; HYPERALGESIA; MALE; MEDICINE, KAMPO; MICE; MICE, INBRED BALB C; ORGANOPLATINUM COMPOUNDS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 84861331815     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.08.009     Document Type: Article

References (32)

1. J. Cassidy, and J.L. Misset Oxaliplatin-related side effects: characteristics and management Semin Oncol 29 2002 11 20
2. J.M. Extra, M. Marty, S. Brienza, and J.L. Misset Pharmacokinetics and safety profile of oxaliplatin Semin Oncol 25 1998 13 22
3. L.M. Pasetto, M.R. D'Andrea, E. Rossi, and S. Monfardini Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 59 2006 159 168
4. S. Quasthoff, and H.P. Hartung Chemotherapy-induced peripheral neuropathy J Neurol 249 2002 9 17
5. A. de Gramont, J. Vignoud, and C. Tournigand Oxalipaltin/5FU/LV in adjuvant colon cancer: safety results of the international randomized MOSAIC trial Prc Am Soc Clin Oncol 21 2002 132
6. R.H. Wilson, T. Lehky, and R.R. Thomas Acute oxaliplatin-induced peripheral nerve hyperexcitability J Clin Oncol 20 2002 1767 1774
7. A. de Gramont, A. Figer, and M. Seymour Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
8. J.L. Misset Oxaliplatin in practice Br J Cancer 77 1998 4 7
9. C. Tournigand, A. Cervantes, and A. Figer OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer - a GERCOR study J Clin Oncol 24 2006 394 400
10. E. Gamelin, L. Gamelin, L. Bossi, and S. Quasthoff Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures Semin Oncol 29 2002 21 33
11. L. Gamelin, M. Boisdron-Celle, and R. Delva Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer Clin Cancer Res 10 2004 4055 4061
12. M.A. Graham, G.F. Lockwood, and D. Greenslade Clinical pharmacokinetics of oxaliplatin: a critical review Clin Cancer Res 6 2000 1205 1218
13. M. Sakurai, N. Egashira, and T. Kawashiri Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia Pain 147 2009 165 174
14. M. Tawata, A. Kurihara, and K. Nitta The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy Diabetes Res Clin Pract 26 1994 121 128
15. T. Uno, I. Ohsawa, M. Tokudome, and Y. Sato Effects of goshajinkigan on insulin resistance in patients with type 2 diabetes Diabetes Res Clin Pract 69 2005 129 135
16. Y. Usuki, S. Usuki, and S. Hommura Successful treatment of a senile diabetic woman with cataract with goshajinkigan Am J Chin Med 19 1991 259 263
17. Kono T, Mamiya N, Chisato N, et al. Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med, in press.
18. Nishioka M, Shimada M, Kurita N, et al. The Kampo medicine, goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol, in press.
19. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110
20. Y. Suzuki, K. Goto, A. Ishige, Y. Komatsu, and J. Kamei Antinociceptive effect of gosha-jinki-gan, a Kampo medicine, in streptozotocin-induced diabetic mice Jpn J Pharmacol 79 1999 169 175
21. Y. Suzuki, K. Goto, A. Ishige, Y. Komatsu, and J. Kamei Antinociceptive mechanism of Gosha-jinki-gan in streptozotocin-induced diabetic animals: role of nitric oxide in the periphery Jpn J Pharmacol 79 1999 387 391
22. N. Egashira, S. Hirakawa, and T. Kawashiri Mexiletine reverses oxaliplatin-induced neuropathic pain in rats J Pharmacol Sci 112 2010 473 476
23. T. Kawashiri, N. Egashira, and H. Watanabe Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model Eur J Pain 15 2011 344 350
24. S.J. Flatters, and G.J. Bennett Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy Pain 109 2004 150 161
25. P. Gauchan, T. Andoh, A. Kato, and Y. Kuraishi Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice Neurosci Lett 458 2009 93 95
26. A.M. Peier, A. Moqrich, and A.C. Hergarden A TRP channel that senses cold stimuli and menthol Cell 108 2002 705 715
27. Y. Suzuki, K. Goto, A. Ishige, Y. Komatsu, and J. Kamei Effects of gosha-jinki-gan, a kampo medicine, on peripheral tissue blood flow in streptozotocin-induced diabetic rats Method Find Exp Clin Pharmacol 20 1998 321 328
28. Y. Niwa, and Y. Miyachi Antioxidant action of natural health products and Chinese herbs Inflammation 10 1986 79 91
29. B.J. Kim, J.H. Kim, H.P. Kim, and M.Y. Heo Biological screening of 100 plant extracts for cosmetic use (II): anti-oxidative activity and free radical scavenging activity Int J Cosmet Sci 19 1997 299 307
30. T. Imamura, O. Ishizuka, and N. Aizawa Gosha-jinki-gan reduces transmitter proteins and sensory receptors associated with C fibre activation induced by acetic acid in rat urinary bladder Neurourol Urodyn 27 2008 832 837
31. P. Gauchan, T. Andoh, A. Kato, A. Sasaki, and Y. Kuraishi Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice J Pharmacol Sci 109 2009 469 472
32. E.K. Joseph, X. Chen, O. Bogen, and J.D. Levine Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy J Pain 9 2008 463 472